Malladi Drugs And Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Chennai, Tamil Nadu, India, established in 1980.
1980 Chennai, Tamil Nadu, India Active
Last Updated:
About Malladi Drugs And Pharmaceuticals Limited

Malladi Drugs And Pharmaceuticals Limited, a active public limited company, was established on 21 August 1980 in Chennai, Tamil Nadu, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230TN1980PLC008382. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹70.00 Cr and a paid-up capital of ₹63.93 Cr.

It upholds a compliant status. Employing 832 professional, Its leadership includes Tirunelveli Padmanabhan Devarajan (Nominee Director), Hariharan Sivaramakrishnan (Director), Sandip Neogi (Cfo). Past directors included Lawrance Mohan Roy, Aaditiyaa Manickavelu Thevandavakkam, Rajiv Sarman Shukla. It holds ₹361.33 Cr open charges and ₹895.47 Cr settled loans. Its latest AGM occurred on 15 July 2025, with the balance sheet filed on 31 March 2025. It is based at Skcl Tech Square, 7Th Floor, Plot No. Sp 14, Thiru Vi Ka Industrial Estate, Guindy, Chennai, Tamil Nadu, 600032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TN1980PLC008382

  • Registration Number

    008382

  • Incorporation Date

    21 August 1980

  • Authorized Capital

    ₹70.00 Cr

  • Paid-Up Capital

    ₹63.93 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 70.00 Cr
  • Paid Up Capital ₹ 63.93 Cr
  • Company Age 45 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 361.33 Cr
  • Satisfied Charges ₹ 895.47 Cr
  • Revenue Growth **** 9.68%
  • Profit Growth **** -16.07%
  • Ebitda **** 3.59%
  • Net Worth 11.55%
  • Total Assets **** 5.67%
Company report

Malladi Drugs And Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Malladi Drugs And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Malladi Drugs And Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Tirunelveli Padmanabhan Devarajan Nominee Director 28 Mar 2022 Current
Hariharan Sivaramakrishnan Director 29 Aug 2023 Current
Sandip Neogi Cfo 30 Aug 2023 Current
Subramanian Vishar Vasudevan Nominee Director 28 Mar 2022 Current
Parvathi Malladi Director 24 Jul 2018 Current
Revathi Raghunathan Director 27 Aug 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Alternate Director 28 Jan 2013 Past
Pramod Abcsdd Director 18 Oct 2012 Past
Pramod Abcsdd Nominee Director 22 Jan 2010 Past
Pramod Abcsdd Additional Director 28 Mar 2022 Past
Pramod Abcsdd Nominee Director 07 Feb 2013 Past
Pramod Abcsdd Nominee Director 07 Apr 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Malladi Drugs And Pharmaceuticals.

Malladi Drugs And Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.68% increase. The company also saw a substantial fall in profitability, with a 16.07% decrease in profit. The company's net worth Soared by an impressive increase of 11.55%.

Malladi Drugs And Pharmaceuticals revenue growth over time
Malladi Drugs And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
9.68%
*******
*******
*******
*******
Revenue from Operations
*******
9.06%
*******
*******
*******
*******
Total Assets
*******
5.67%
*******
*******
*******
*******
Profit or Loss
*******
-16.07%
*******
*******
*******
*******
Net Worth
*******
11.55%
*******
*******
*******
*******
EBITDA
*******
3.59%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Malladi Drugs And Pharmaceuticals?

In 2024, Malladi Drugs And Pharmaceuticals had a promoter holding of 11.68% and a public holding of 88.31%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,613,310,957.00

Satisfied Charges

₹8,954,746,768.00

Charges Breakdown by Lending Institutions
  • Others : 135.00 Cr
  • Axis Bank Limited : 83.45 Cr
  • State Bank Of India : 75.00 Cr
  • Hdfc Bank Limited : 67.70 Cr
  • First Leasing Co Of India Limited : 0.18 Cr
Latest Charge Details
Date Lender Amount Status
14 May 2025 State Bank Of India ₹75.00 Cr Open
16 Jun 2023 Hdfc Bank Limited ₹67.70 Cr Open
18 Mar 2023 Axis Bank Limited ₹6.50 Cr Open
27 Jan 2023 Others ₹105.00 Cr Open
20 Dec 2022 Others ₹10.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Malladi Drugs And Pharmaceuticals?

Malladi Drugs And Pharmaceuticals has a workforce of 832 employees as of Mar 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Malladi Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malladi Drugs And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Malladi Drugs And Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 16 Oct 2006 via Charge ID 10026699 with Others was fully satisfied on 29 Oct 2025. was completed.

  • Annual General Meeting

    The activity Malladi Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 15 Jul 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 75.00 Cr with Charge ID 101099419 was registered on 14 May 2025. was documented.

  • Balance Sheet

    The activity Malladi Drugs And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Director Appointment

    Revathi Raghunathan was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 67.70 Cr registered on 16 Jun 2023 with Charge ID 100739974 was modified on 29 Jan 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Malladi Drugs And Pharmaceuticals Limited?

The CIN of Malladi Drugs And Pharmaceuticals Limited is U24230TN1980PLC008382.

Where is Malladi Drugs And Pharmaceuticals Limited headquartered?

Malladi Drugs And Pharmaceuticals Limited is headquartered at Skcl Tech Square, 7Th Floor, Plot No. Sp 14, Thiru Vi Ka Industrial Estate, Guindy, Chennai, Tamil Nadu, 600032.

When was Malladi Drugs And Pharmaceuticals Limited incorporated?

Malladi Drugs And Pharmaceuticals Limited was incorporated on 21 August 1980.

Who are the current directors of Malladi Drugs And Pharmaceuticals Limited?
What is the primary industry of Malladi Drugs And Pharmaceuticals Limited?

The primary industry of Malladi Drugs And Pharmaceuticals Limited is Manufacturing.

Is Malladi Drugs And Pharmaceuticals Limited a listed company?

Malladi Drugs And Pharmaceuticals Limited is unlisted.

What is the capital structure of Malladi Drugs And Pharmaceuticals Limited?

The authorized capital of Malladi Drugs And Pharmaceuticals Limited is ₹70.00 Cr, and the paid-up capital is ₹63.93 Cr.

What is the compliance status of Malladi Drugs And Pharmaceuticals Limited?

The compliance status of Malladi Drugs And Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available